PubMed HealthSearch

Biomedical subjects

B Weirich

Publications and source records attributed to B Weirich.

2 recordsLinked to original sources

Decrease in sensitisation rate and intestinal anaphylactic response after nitric oxide synthase inhibition in a food hypersensitivity model.

BACKGROUND: Although nitric oxide (NO) has been found to have a role in gut inflammation and to modulate immunoglobulin production, little is known about its part in food hypersensitivities. AIM: This study aimed to evaluate the role of NO through the inhibition of constitutive and inducible NO synthase (cNOS and iNOS respectively) on the sensitisation process (antibody titres) and on intestinal anaphylactic responses (colonic hypersecretion upon antigen challenge). ANIMALS AND METHODS: Guinea pigs sensitised to cow's milk proteins were treated either during the sensitisation period or before antigen challenge by N-nitro-L-arginine methyl ester (L-NAME) (inhibiting both cNOS and iNOS) or amino-guanidine (selective iNOS inhibitor). RESULTS: Chronic treatment by L-NAME or aminoguanidine reduced antibody titres and the secretory response to antigen challenge. In contrast, only L-NAME administered before challenge was able to antagonise the hypersecretion induced by the challenge. CONCLUSIONS: NO generated by iNOS has a role in the sensitisation process: iNOS inhibition results in lower rates of antibodies leading to a reduced secretory response upon challenge. In contrast, blockade of colonic hypersecretion by L-NAME but not by aminoguanidine suggests that NO via cNOS is a key mediator in intestinal anaphylactic reactions.

Animals

Effects of rigid gas permeable contact lens solutions on the human corneal epithelium.

In this investigation, the effects of three rigid gas permeable (RGP) contact lens wetting and soaking solutions, Boston Advance Conditioning Solution, Boston Conditioning Solution, and Allergan Wet-N-Soak Plus, were tested on the human corneal epithelium. Thirty subjects participated in three experimental sessions, during which one eye received three drops of one of these RGP solutions, while the other eye served as a control. After 10 and 30 min, corneal staining was graded in 5 areas and the eyes were photographed for a digitized analysis of staining. Our results indicate that corneas exposed to Boston Advance Conditioning Solution demonstrated significantly more fluorescein staining than control eyes at both 10 and 30 min by both methods of analysis, whereas corneas treated with the other two solutions were not significantly different from controls. The increased corneal staining noted with Boston Advance Conditioning Solution may be caused by the presence and concentration of the preservative, 0.0015% polyaminopropyl biguanide. An unforeseen result of this experiment was the relatively large number of subjects exposed to Boston Conditioning Solution and Allergan Wet-N-Soak Plus who had more corneal staining in the control eye. This may suggest that the two RGP solutions served as a barrier to fluorescein, protecting the epithelial cells from staining.

Adolescent